RT Book, Section A1 Reynolds, Kerry A1 Ananthakrishnan, Ashwin A1 Dougan, Michael A1 Bardia, Aditya A2 McKean, Sylvia C. A2 Ross, John J. A2 Dressler, Daniel D. A2 Scheurer, Danielle B. SR Print(0) ID 1137618815 T1 Immune-Related Adverse Events (irAEs) in Cancer Patients T2 Principles and Practice of Hospital Medicine, 2e YR 2017 FD 2017 PB McGraw-Hill Education PP New York, NY SN 9780071843133 LK accessmedicine.mhmedical.com/content.aspx?aid=1137618815 RD 2022/08/08 AB Key Clinical Questions When should immune-related adverse events (irAEs) be suspected in acutely ill hospitalized oncology patients? How do you evaluate an oncology patient who may have an irAE related to immunotherapy treatment? How do you manage patients with irAEs? What should you consider when discharging a patient that has been treated for an irAE?